Complement C5
From Proteopedia
(Difference between revisions)
												
			
			| (7 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| - | <StructureSection load='  | + | <StructureSection load='' size='350' side='right' caption='Human complement C5 complex (green) with cobra venom factor (magenta) (PDB code [[3pvm]])' scene='70/705685/Cv/6'>  | 
__TOC__  | __TOC__  | ||
== Function ==  | == Function ==  | ||
| - | '''Complement C5''' (CC5) is the fifth component of the complement system.  The complement system is part of the innate immune system.  CC5 is composed of α chain (C5a) and β chain (C5b).  Proteoplytic degradation of CC5 produces <scene name='70/705685/Cv/  | + | '''Complement C5''' (CC5) is the fifth component of the complement system.  The complement system is part of the innate immune system.  CC5 is composed of α chain (C5a) and β chain (C5b).  Proteoplytic degradation of CC5 produces <scene name='70/705685/Cv/4'>anaphylatoxin</scene> which is a mediator of local inflammatory process.  The C terminal domain of CC5 (residues 1530-1676) is homologous to a domain in netrins and is named <scene name='70/705685/Cv/5'>C345C</scene>.  Activation of CC5 by C5 convertase initiates the assembly of the C5 to C9 components into the membrane attack complex. <ref>PMID:18536718</ref>  | 
== Disease ==  | == Disease ==  | ||
Mutations in CC5 cause a deficiency leading to severe recurrent infections and are linked to liver fibrosis, Leiner's disease and rheumatoid arthritis.  | Mutations in CC5 cause a deficiency leading to severe recurrent infections and are linked to liver fibrosis, Leiner's disease and rheumatoid arthritis.  | ||
| - | </StructureSection>  | ||
== 3D Structures of complement C5 ==  | == 3D Structures of complement C5 ==  | ||
| + | [[Complement C5 3D structures]]  | ||
| - | + | </StructureSection>  | |
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | **[[1kjs]], [[3hqa]], [[3hqb]] – hCC5  <BR />  | ||
| - | **[[4p3a]], [[4p3b]] – mCC5 - mouse <BR />  | ||
| - | **[[4wb3]], [[4wb2]] – mCC5 + DNA/RNA  <BR />  | ||
| - | }}  | ||
== References ==  | == References ==  | ||
<references/>  | <references/>  | ||
| + | [[Category:Topic Page]]  | ||
Current revision
  | |||||||||||
References
- ↑ Fredslund F, Laursen NS, Roversi P, Jenner L, Oliveira CL, Pedersen JS, Nunn MA, Lea SM, Discipio R, Sottrup-Jensen L, Andersen GR. Structure of and influence of a tick complement inhibitor on human complement component 5. Nat Immunol. 2008 Jul;9(7):753-60. Epub 2008 Jun 8. PMID:18536718 doi:10.1038/ni.1625
 

